Global Spatial Proteomics Market Size to Reach USD 400.10 Million by 2035 at 15.05% CAGR – SNS Insider
U.S. market to reach USD 156.90M and Europe USD 96.02M by 2035, driven by pharma R&D, biomarker development and multiplexed imaging.
Austin, United States, Aug. 21, 2026 (GLOBE NEWSWIRE) — The global Spatial Proteomics Market was valued at USD 98.45 Million in 2025 and is projected to reach USD 400.10 Million by 2035, expanding at a CAGR of 15.05% from 2026 to 2035. Market growth is being supported by breakthroughs in precision oncology, multiplexed protein imaging, protein mapping using mass spectrometry, and artificial intelligence.
Research access: Download the Spatial Proteomics Market Sample Report
Spatial Proteomics Market Growth Drivers: Precision Oncology, High-Plex Imaging and AI
The increasing use of spatial proteomics in precision oncology is increasing the need for protein profiling at the tissue level where proteins can be studied in terms of their expression, localization, and interactions while preserving the morphological aspects of the sample. This increased need is also being supported through the use of multiplexed imaging, mass spectrometry, and artificial intelligence analysis platforms by pharma/biotech companies and others.
Key Spatial Proteomics Market Takeaways
- Global market size: USD 98.45 Million in 2025; projected to reach USD 400.10 Million by 2035.
- Forecast CAGR: 15.05% from 2026 to 2035.
- Leading product: Instruments, with approximately 43.20% share in 2025.
- Leading technology: Imaging-Based, with approximately 51.80% share in 2025.
- Leading sample type: FFPE, with approximately 58.60% share in 2025.
- Leading end user: Academic & Research Institutes, with approximately 52.40% share in 2025.
- Largest regional market: North America, with approximately 45.60% share in 2025.
- Fastest-growing regional market: Asia Pacific.
Spatial Proteomics Market Regional Analysis
North America held approximately 45.60% of the global market in 2025 due to its advanced biotech and pharma research ecosystem, heavy investments in precision oncology and translational research, and use of multiplexed imaging and mass spectrometry protein detection technologies. This is in addition to the presence of many instrumentation providers, CROs, and spatial biology core laboratories.
The U.S. Spatial Proteomics Market was valued at approximately USD 39.10 Million in 2025 and is forecast to reach about USD 156.90 Million by 2035, growing at a CAGR of 14.90% from 2026 to 2035. Growth is driven by investment in the field of pharmaceutical and biotechnological research, availability of instruments and reagents for spatial proteomics, and multiplexed protein imaging.
The Europe Spatial Proteomics Market was valued at USD 22.64 Million in 2025 and is projected to reach USD 96.02 Million by 2035, growing at a CAGR of 15.54% from 2026 to 2035. Regional growth is driven by developments in molecular biology, funds invested in precision oncology and immunology research, and the pharmaceutical industry’s drug biomarker development efforts.
The Asia Pacific region is seen to be the highest growing regional market due to increased expenditures on biopharmaceutical R&D, government funding for precision medicines and genomics, and increased spatial biology core facilities in China, Japan, South Korea, among others. The China region makes up approximately 42.60% of the regional revenue, thanks to the growing biopharmaceutical production and research market environment and also the presence of spatial biology instruments in China.
Spatial Proteomics Market Segmentation Analysis
By Product: Instruments segment is leading the global market with an approximate 43.20% share in 2025, signifying its significance in terms of the high-resolution and multiplexed protein imaging in addition to the mass spectrometry study. Software & Services is anticipated to be the fastest growing category of products, which is forecasted to grow at a CAGR of 17.40% during 2026-2035.
By Technology: Imaging-Based technology market share was valued at approximately 51.80% in 2025 owing to multiplexed immunofluorescence, imaging mass cytometry, and immunohistochemistry. Mass spectrometry technology Mass Spectrometry-Based technology is expected to be the fastest growing, exhibiting a CAGR of 16.90% during the period 2026-2035 owing to rising demand for label-free and ultra-sensitive protein detection, laser micro-dissection, and MALDI imaging.
By Sample Type: FFPE held the largest market share of about 58.60% in 2025 because of its extensive availability in pathology laboratories, ability to store at room temperature, and imaging-friendly nature. Fresh Frozen Tissues is the fastest growing sample type segment with a CAGR of 15.60% during the forecast period from 2026 to 2035 owing to their preservation capabilities of proteins, RNA, and molecular structure.
By End User: Academic & Research Institutes held approximately 52.40% share in 2025, supported by government and foundation funding and the establishment of spatial biology core facilities. Pharmaceutical & Biotechnology Companies are the fastest-growing end-user segment, with a CAGR of 16.60% from 2026 to 2035, reflecting increased investment in precision medicine drugs and biomarker studies.
Full market analysis: View the Complete Spatial Proteomics Market Report
Spatial Proteomics Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 98.45 Million |
| Market Size by 2035 | USD 400.10 Million |
| CAGR | CAGR of 15.05% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Product (Instruments, Reagents & Consumables, Software & Services) • By Technology (Imaging-Based, Mass Spectrometry-Based, Sequencing-Based) • By Sample Type (FFPE, Fresh Frozen Tissue) • By End User(Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Contract Research Organizations) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Spatial Proteomics Market Companies and Competitive Landscape
- 10x Genomics, Inc.
- Bruker Corporation
- Standard BioTools Inc.
- Akoya Biosciences, Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- Danaher Corporation
- Bio-Techne Corporation
- Revvity, Inc.
- Ionpath, Inc.
- Lunaphore Technologies SA
- Nikon Instruments Inc.
- S2 Genomics, Inc.
- Seven Bridges Genomics, Inc.
- Ultivue, Inc.
- Visiopharm A/S
- Vizgen, Inc.
Recent Spatial Proteomics Market Developments
- 2025: 10x Genomics completed its acquisition of RareCyte for USD 200 Million, integrating RareCyte’s Orion spatial biology imaging platform to expand high-plex protein imaging capabilities.
- 2026: Akoya Biosciences launched PhenoCycler Fusion 2.0, an upgraded multiplexed imaging system enabling researchers to detect an expanded panel of protein biomarkers within a single tissue section.
Purchase access: Buy the Spatial Proteomics Market Report – Competitive Analysis & 2035 Forecast
Why Buy the Spatial Proteomics Market Report?
- Precision oncology intelligence: Assess adoption in tumor microenvironment analysis, biomarker discovery, and personalized cancer research.
- High-plex protein mapping outlook: Understand the role of imaging platforms that visualize multiple proteins while preserving tissue architecture and spatial context.
- AI and bioinformatics trends: Track the growing role of AI-driven spatial data analysis, protein mapping, and multi-modal data interpretation.
- Market sizing and forecast: Compare the USD 98.45 Million 2025 market with the USD 400.10 Million 2035 forecast and 15.05% CAGR.
- Regional opportunity analysis: Review North America leadership, U.S. and Europe forecasts, and Asia Pacific growth dynamics.
- Technology and segment analysis: Evaluate imaging-based, mass spectrometry-based, product, sample type, and end-user market dynamics.
Related Market Reports
Spatial Omics Market Size 2026
Spatial Computing Platform Market Outlook 2026
Single-cell Omics Market Trends 2026
Single-cell Analysis Market Size 2026
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315-961-9094 (US) Email: [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. UKNewshour.com takes no editorial responsibility for the same.
